Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors

NCT05579275 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Malignant Solid Tumors

Interventions

BIOLOGICAL: JCXH-212 Injection

Sponsor

Peking University Cancer Hospital & Institute